Shasqi Inc

10/18/2025 | Press release | Archived content

Tumor-Selective MMAE Activation via CEACAM5 Pre-Targeting Using Click Chemistry: A First-in-Class Strategy to Enhance Clinical Benefit

Tumor-Selective MMAE Activation via CEACAM5 Pre-Targeting Using Click Chemistry: A First-in-Class Strategy to Enhance Clinical Benefit

October 18, 2025

Shasqi presented the scientific poster titled, Tumor-Selective MMAE Activation via CEACAM5 Pre-Targeting Using Click Chemistry: A First-in-Class Strategy to Enhance Clinical Benefit, on October 18, 2025 at the European Society for Medical Oncology (ESMO) Congress in Berlin, Germany.

View the abstract here.

Shasqi Inc published this content on October 18, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 06:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]